Mesoblast
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Mesoblast and other ETFs, options, and stocks.About MESO
Mesoblast Ltd. is a biopharmaceutical company, which engages in the research, development, and market of mesenchymal lineage adult stem cell technology platform. Its medicines target cardiovascular diseases, spine orthopedic disorders, oncology and hematology, immune-mediated, and inflammatory diseases.
CEOSilviu Itescu
CEOSilviu Itescu
Employees81
Employees81
HeadquartersMelbourne, Victoria (VIC)
HeadquartersMelbourne, Victoria (VIC)
Founded2004
Founded2004
Employees81
Employees81
MESO Key Statistics
Market cap2.01B
Market cap2.01B
Price-Earnings ratio-18.43
Price-Earnings ratio-18.43
Dividend yield—
Dividend yield—
Average volume152.86K
Average volume152.86K
High today$15.93
High today$15.93
Low today$15.58
Low today$15.58
Open price$15.72
Open price$15.72
Volume111.83K
Volume111.83K
52 Week high$22.00
52 Week high$22.00
52 Week low$8.35
52 Week low$8.35
Stock Snapshot
As of today, Mesoblast(MESO) shares are valued at $15.59. The company's market cap stands at 2.01B, with a P/E ratio of -18.43.
As of 2025-11-05, Mesoblast(MESO) stock has fluctuated between $15.58 and $15.93. The current price stands at $15.59, placing the stock +0.1% above today's low and -2.1% off the high.
The Mesoblast(MESO)'s current trading volume is 111.83K, compared to an average daily volume of 152.86K.
In the last year, Mesoblast(MESO) shares hit a 52-week high of $22.00 and a 52-week low of $8.35.
In the last year, Mesoblast(MESO) shares hit a 52-week high of $22.00 and a 52-week low of $8.35.
Analyst ratings
86%
of 7 ratingsBuy
85.7%
Hold
14.3%
Sell
0%